Citizens Financial Group Inc. RI Takes Position in Cardlytics, Inc. $CDLX

Citizens Financial Group Inc. RI acquired a new position in Cardlytics, Inc. (NASDAQ:CDLX) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 518,663 shares of the company’s stock, valued at approximately $1,260,000. Citizens Financial Group Inc. RI owned approximately 0.97% of Cardlytics at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of CDLX. Lane Generational LLC increased its position in Cardlytics by 28.0% in the second quarter. Lane Generational LLC now owns 780,083 shares of the company’s stock worth $1,283,000 after buying an additional 170,480 shares in the last quarter. Jane Street Group LLC increased its holdings in Cardlytics by 263.0% in the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock worth $267,000 after acquiring an additional 117,687 shares in the last quarter. XTX Topco Ltd raised its stake in Cardlytics by 143.5% during the 2nd quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock worth $141,000 after acquiring an additional 50,663 shares during the period. Marshall Wace LLP purchased a new position in Cardlytics during the second quarter valued at approximately $59,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Cardlytics in the second quarter worth approximately $42,000. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CDLX shares. Wall Street Zen downgraded shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Three research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $2.25.

Cardlytics Price Performance

Shares of NASDAQ:CDLX opened at $1.29 on Thursday. The firm has a market cap of $69.73 million, a price-to-earnings ratio of -0.61, a P/E/G ratio of 0.19 and a beta of 1.05. The firm has a fifty day moving average price of $1.21 and a 200 day moving average price of $1.58. Cardlytics, Inc. has a fifty-two week low of $0.85 and a fifty-two week high of $4.05. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.14 and a current ratio of 1.14.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.08. The business had revenue of $52.03 million for the quarter, compared to analysts’ expectations of $56.64 million. Cardlytics had a negative net margin of 44.12% and a negative return on equity of 235.70%. As a group, sell-side analysts expect that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Cardlytics Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.